Qualigen Therapeutics | 8-K: Current report
Apr 16 16:16 ET
Qualigen Therapeutics | 10-K: Annual report
Apr 8 06:07 ET
Qualigen Therapeutics | NT 10-K: Others
Apr 1 14:37 ET
Qualigen Therapeutics | 8-K: Current report
Mar 28 16:10 ET
Qualigen Therapeutics | 8-K: Current report
Feb 27 07:05 ET
Qualigen Therapeutics | 8-K: Current report
Feb 22 16:13 ET
Qualigen Therapeutics | 8-K: Current report
Dec 7, 2023 16:15 ET
Qualigen Therapeutics | 8-K: Current report
Nov 22, 2023 16:30 ET
Qualigen Therapeutics | 8-K: Current report
Nov 14, 2023 17:10 ET
Qualigen Therapeutics: Q3 2023 Earnings Report
Nov 14, 2023 16:54 ET
Qualigen Therapeutics | 8-K: Current report
Nov 8, 2023 14:16 ET
Qualigen Therapeutics | 8-K: Current report
Oct 17, 2023 08:30 ET
Qualigen Therapeutics | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)
Oct 2, 2023 20:04 ET
Qualigen Therapeutics | 424B3: Prospectus
Sep 29, 2023 16:30 ET
Qualigen Therapeutics | 8-K: Current report
Sep 28, 2023 16:15 ET
Qualigen Therapeutics | EFFECT: Others
Sep 8, 2023 00:15 ET
Qualigen Therapeutics | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing
Sep 1, 2023 16:15 ET
Qualigen Therapeutics | 8-K: Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 30, 2023
Aug 15, 2023 10:04 ET
Qualigen Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 14, 2023 16:16 ET
Qualigen Therapeutics | 8-K: Current report
Aug 4, 2023 16:30 ET
No Data
No Data